Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gelbard

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Population Today|September 28, 2002
Population 101. A primerA Gelbard
Annals of the New York Academy of Sciences|February 11, 2000
Neuroprotective strategies for HIV-1-associated neurologic diseaseH A Gelbard
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 25, 2017
Neuroimmune Pharmacology, 2nd Edition - A PerspectiveHarris A Gelbard
The Journal of Clinical Investigation|January 15, 2004
Synapses and Sisyphus: life without parapleginHarris A Gelbard
Population Today|September 27, 2002
Population "explosion" not over for half the worldA Gelbard, C Haub
Nature Microbiology|April 23, 2024
SARS and synapsesHarris A Gelbard, Wesley Chiang
Neurology|January 2, 2020
The darker side of varicella zoster infection: Arterial ischemic strokeSteven Pavlakis, Harris A Gelbard
Current Opinion in HIV and AIDS|September 17, 2014
Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disordersHoward E Gendelman, Harris A Gelbard
Neurology|September 13, 2013
Lipids and cognition make good bedfellows for neuroAIDSHarris A Gelbard, Howard E Gendelman
Matters|May 10, 2021
The Cell Culture Environment Regulates the Transcription Factor MafB in BV-2 MicrogliaPatrick Miller-Rhodes, Harris A Gelbard
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Population Today|September 28, 2002
Population 101. A primerA Gelbard
Annals of the New York Academy of Sciences|February 11, 2000
Neuroprotective strategies for HIV-1-associated neurologic diseaseH A Gelbard
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 25, 2017
Neuroimmune Pharmacology, 2nd Edition - A PerspectiveHarris A Gelbard
The Journal of Clinical Investigation|January 15, 2004
Synapses and Sisyphus: life without parapleginHarris A Gelbard
Population Today|September 27, 2002
Population "explosion" not over for half the worldA Gelbard, C Haub
Nature Microbiology|April 23, 2024
SARS and synapsesHarris A Gelbard, Wesley Chiang
Neurology|January 2, 2020
The darker side of varicella zoster infection: Arterial ischemic strokeSteven Pavlakis, Harris A Gelbard
Current Opinion in HIV and AIDS|September 17, 2014
Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disordersHoward E Gendelman, Harris A Gelbard
Neurology|September 13, 2013
Lipids and cognition make good bedfellows for neuroAIDSHarris A Gelbard, Howard E Gendelman
Matters|May 10, 2021
The Cell Culture Environment Regulates the Transcription Factor MafB in BV-2 MicrogliaPatrick Miller-Rhodes, Harris A Gelbard
Pageof 15